Company performance
Add to research
Current Price
as of Feb 17, 2025$106.33
P/E Ratio
18.37
Market Cap
$209.17B
Description
Add to research
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Metrics
Add to research
Overview
- HQBasel, BS
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerNOVN
- Price$106.327568+0.69%
Trading Information
- Market cap$209.17B
- Float89.22%
- Average Daily Volume (1m)3,625,811
- Average Daily Volume (3m)3,494,556
- EPS$5.21
Company
- Revenue$44.31B
- Rev growth (1yr)8.52%
- Net income$10.52B
- Gross margin74.07%
- EBITDA margin42.40%
- EBITDA$18.79B
- EV$196.71B
- EV/Revenue4.44
- P/E18.37
- P/S4.40
- P/B4.74
- Debt/Equity70.97
Documents
Add to research
Factset Street Account
Wikipedia